Total Payments
$651.62
2024 Payments
$18.09
Companies
9
Transactions
11
Medicare Patients
2,336
Medicare Billing
$391,942
Payment Breakdown by Category
Food & Beverage$633.53 (97.2%)
Education$18.09 (2.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $633.53 | 10 | 97.2% |
| Education | $18.09 | 1 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $219.84 | 2 | $0 (2019) |
| Genentech USA, Inc. | $125.00 | 1 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $125.00 | 1 | $0 (2019) |
| UCB, Inc. | $83.41 | 1 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $28.19 | 2 | $0 (2017) |
| Allergan, Inc. | $24.24 | 1 | $0 (2020) |
| Merck Sharp & Dohme LLC | $18.09 | 1 | $0 (2024) |
| LivaNova USA, Inc. | $15.86 | 1 | $0 (2017) |
| ABBVIE INC. | $11.99 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.09 | 1 | Merck Sharp & Dohme LLC ($18.09) |
| 2022 | $11.99 | 1 | ABBVIE INC. ($11.99) |
| 2020 | $24.24 | 1 | Allergan, Inc. ($24.24) |
| 2019 | $239.56 | 2 | Teva Pharmaceuticals USA, Inc. ($125.00) |
| 2018 | $105.28 | 1 | GENZYME CORPORATION ($105.28) |
| 2017 | $252.46 | 5 | Genentech USA, Inc. ($125.00) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/28/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Central Nervous System | ||||||
| 05/07/2019 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $114.56 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 03/01/2018 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $105.28 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/11/2017 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: VNS Therapy (Product Class) | ||||||
| 05/02/2017 | Genentech USA, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: None | ||||||
| 05/01/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: CNS | ||||||
| 04/10/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $8.37 | General |
| Category: CNS | ||||||
| 02/20/2017 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $83.41 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 546 | 9,173 | $249,544 | $94,843 |
| 2022 | 14 | 600 | 12,330 | $297,165 | $112,921 |
| 2021 | 16 | 630 | 10,684 | $266,629 | $104,772 |
| 2020 | 14 | 560 | 8,853 | $219,768 | $79,406 |
Total Patients
2,336
Total Services
41,040
Medicare Billing
$391,942
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 25 | 8,421 | $84,210 | $39,895 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 253 | $54,648 | $20,128 | 36.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 141 | $21,432 | $8,202 | 38.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 35 | $14,770 | $4,406 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 80 | $12,480 | $4,190 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $10,016 | $3,906 | 39.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 38 | 50 | $9,850 | $3,471 | 35.2% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 11 | 32 | $17,093 | $3,263 | 19.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 46 | $5,014 | $1,799 | 35.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 18 | $5,166 | $1,742 | 33.7% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 19 | 19 | $5,795 | $1,316 | 22.7% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 12 | 12 | $4,320 | $1,092 | 25.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 19 | 20 | $3,000 | $840.40 | 28.0% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 11 | 14 | $1,750 | $591.34 | 33.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 30 | 11,534 | $115,340 | $51,353 | 44.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 262 | $56,592 | $20,922 | 37.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 47 | 47 | $19,834 | $6,987 | 35.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 58 | 118 | $17,936 | $6,294 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 55 | 55 | $17,215 | $6,035 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 97 | $15,132 | $5,983 | 39.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 40 | 48 | $9,456 | $3,555 | 37.6% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 11 | 32 | $17,312 | $3,388 | 19.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 62 | $6,758 | $2,568 | 38.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 16 | 16 | $7,360 | $1,863 | 25.3% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 14 | 14 | $5,040 | $1,394 | 27.7% |
About Dr. James Fesenmeier, MD
Dr. James Fesenmeier, MD is a Neurology healthcare provider based in Avon, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649294166.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Fesenmeier, MD has received a total of $651.62 in payments from pharmaceutical and medical device companies, with $18.09 received in 2024. These payments were reported across 11 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($633.53).
As a Medicare-enrolled provider, Fesenmeier has provided services to 2,336 Medicare beneficiaries, totaling 41,040 services with total Medicare billing of $391,942. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Avon, IN
- Active Since 07/27/2006
- Last Updated 03/07/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1649294166
Products in Payments
- AUBAGIO (Drug) $219.84
- AJOVY (Drug) $125.00
- Non-Covered Product (Drug) $125.00
- Briviact (Drug) $83.41
- APTIOM (Drug) $28.19
- UBRELVY (Drug) $24.24
- WELIREG (Drug) $18.09
- VNS Therapy (Device) $15.86
- QULIPTA (Drug) $11.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Avon
Christopher Wilson, Md, MD
Neurology — Payments: $437,965
Neurology $437,965
Kylene Huler, M.d, M.D
Neurology — Payments: $4,416
Neurology $4,416
Yolanda Pena, Md, MD
Neurology — Payments: $2,417
Neurology $2,417
Muhammad Bilal, Md, MD
Neurology — Payments: $1,111
Neurology $1,111
Ruth Baird, Md, MD
Neurology — Payments: $463.60
Neurology $463.60
Sadia Saba, Md, MD
Neurology — Payments: $95.30
Neurology $95.30